Multiple endocrine neoplasia type 2A (
MEN 2A) is an autosomal dominant disorder characterized by medullary
thyroid carcinoma,
pheochromocytoma and
primary hyperparathyroidism. The first
tumor is usually a medullary
thyroid carcinoma.
MEN 2A is caused by
mutations in the RET
proto-oncogene. The
detection of
mutations in the
gene has important diagnostic and
therapeutic impacts.
Genetic testing of at-
risk family members allows one to identify individuals
carrying the mutant
alleles with very high
specificity and sensitivity. Subsequently, total
thyroidectomy, recommended at 5 years of age, can be performed in a prophylactic attempt. The authors performed a molecular
analysis to identify a
mutation in a
Thai woman with
MEN 2A. She was found to be heterozygous for 1900T>C (C634R). The
patient had two
daughters who were not found to carry the
mutation. The newly available genetic test for
patients with
MEN 2A in
Thailand makes possible accurate
DNA-based
diagnosis of their at-
risk family members before development of the
disease, which has important
therapeutic impacts for them.